https://www.selleckchem.com/products/torin-1.html
Despite improvements in the management of coronary artery disease, patients remain at risk for very late adverse cardiovascular events both arising from the stented regions and other untreated segments of the coronary tree. Further advancements focused on primary prevention, stent design and procedural technique, and secondary prevention will be crucial to reducing rates of very late events and improving symptoms and prognosis of patients after PCI. Renovascular occlusive disease remains a common cause of resistant and rapidly progressi
Like
Comment
Share
